Do all patients with advanced N-stage nasopharyngeal carcinoma benefit from the addition of induction chemotherapy to concurrent chemoradiotherapy?

Do all patients with advanced N-stage nasopharyngeal carcinoma benefit from the addition of induction chemotherapy to concurrent chemoradiotherapy?

Background: The aim of this study was to evaluate the benefits from the addition of induction chemotherapy (IC) to concurrent chemoradiotherapy (CCRT) in N2-3 nasopharyngeal carcinoma (NPC). Methods: A total of 3089 patients with nonmetastatic NPC, staged as N2-3 were retrospectively reviewed. IC co...

Full description

Bibliographic Details
Main Authors: Ji-Jin Yao, Ya-Nan Jin, Zhi-Gang Liu, Qiao-Dan Liu, Xiao-Feng Pei, Huai-Li Zhou, Wang-Jian Zhang, Fan Zhang, Li Lin, Wayne R. Lawrence, Si-Yang Wang, Jun Ma, Guan-Qun Zhou, Ying Sun
Format: Article
Language:English
Published: SAGE Publishing 2019-03-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/1758835919833863

Internet

https://doi.org/10.1177/1758835919833863

Similar Items